https://keshavmed.com/news/%e7%a0%94%e7%a9%b6%e8%af%84%e4%bc%b0%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%96%97%e6%95%88-f/ 2026-07-11T06:35:43+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb/ 2026-07-11T06:35:43+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-zh-tw/ 2026-07-11T06:35:43+00:00 https://keshavmed.com/news/%e7%a0%94%e7%a9%b6%e8%af%84%e4%bc%b0%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%96%97%e6%95%88-d/ 2026-07-11T06:35:43+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-en/ 2026-07-11T06:35:43+00:00 https://keshavmed.com/news/%e7%a0%94%e7%a9%b6%e8%af%84%e4%bc%b0%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%96%97%e6%95%88-j/ 2026-07-11T06:35:43+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-fr/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e7%a0%94%e7%a9%b6%e8%af%84%e4%bc%b0%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%96%97%e6%95%88-p/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-de/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-ja/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e7%a0%94%e7%a9%b6%e8%af%84%e4%bc%b0%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%96%97%e6%95%88-a/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-pt/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-es/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e7%a0%94%e7%a9%b6%e8%af%84%e4%bc%b0%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%96%97%e6%95%88-r/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-ar/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e7%a0%94%e7%a9%b6%e8%af%84%e4%bc%b0%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%96%97%e6%95%88-i/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-ru/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e7%a0%94%e7%a9%b6%e8%af%84%e4%bc%b0%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%96%97%e6%95%88-t/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-id/ 2026-07-11T06:35:41+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-vi/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-zh-tw/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-en/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-fr/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-de/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-ms/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-ja/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e7%a0%94%e7%a9%b6%e8%af%84%e4%bc%b0%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%96%97%e6%95%88-v/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-th/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e7%a0%94%e7%a9%b6%e8%af%84%e4%bc%b0%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%96%97%e6%95%88-m/ 2026-07-11T06:35:40+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-pt/ 2026-07-11T06:35:39+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-es/ 2026-07-11T06:35:39+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-ar/ 2026-07-11T06:35:39+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-ru/ 2026-07-11T06:35:39+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-zh-tw/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-en/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-fr/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-de/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-ja/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-pt/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-es/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-ar/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-ru/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-id/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-th/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-id/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-vi/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-th/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-vi/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e7%99%8c%e7%9a%84%e7%b1%b3%e6%89%98%e5%9d%a6%e8%be%85%e5%8a%a9%e6%b2%bb%e7%96%97-%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb-2-ms/ 2026-07-11T06:35:38+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-en/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-fr/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-de/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-ja/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-pt/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-es/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-ar/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-ru/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-id/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-th/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-vi/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-ms/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/novo-nordisk-warns-consumers-about-counterfeit-ozempic-semaglutide-injection-1-mg-in-the-us-ms/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-zh-tw/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-en/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/fda-approves-inqovi-in-combination-with-venetoclax-the-first-all-oral-combination-treatment-for-patients-with-acute-myeloid-leukemia-who-are-ineligible-for-intensive-induction-chemotherapy-zh-tw/ 2026-07-11T06:35:37+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-de/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-pt/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-ja/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-es/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-pt/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-es/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-ar/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-ru/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-id/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-th/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-vi/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-ms/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-zh-tw/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-en/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-fr/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-de/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/xspray-pharma-re-submits-its-fda-application-for-dasynoc-fr/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-ja/ 2026-07-11T06:35:36+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-ar/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-ru/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-ar/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-id/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-ru/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-th/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-id/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-vi/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-th/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-vi/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-braftovi-encorafenib-date-of-authorisation-19-09-2018-revision-18-status-authorised-ms/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-zh-tw/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-en/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-fr/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-de/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-ja/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-pt/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-es/ 2026-07-11T06:35:35+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-id/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-th/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-vi/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-ms/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-koselugo-selumetinib-date-of-authorisation-17-06-2021-revision-9-status-authorised-ms/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-zh-tw/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-en/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-zh-tw/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-en/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-fr/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-de/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-ja/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-pt/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-es/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-ar/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/human-medicines-european-public-assessment-report-epar-mulpleo-previously-lusutrombopag-shionogi-lusutrombopag-date-of-authorisation-18-02-2019-revision-9-status-withdrawn-ru/ 2026-07-11T06:35:34+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-vi/ 2026-07-11T06:35:33+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-fr/ 2026-07-11T06:35:33+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-de/ 2026-07-11T06:35:33+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-ja/ 2026-07-11T06:35:33+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-pt/ 2026-07-11T06:35:33+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-es/ 2026-07-11T06:35:33+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-ar/ 2026-07-11T06:35:33+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-ru/ 2026-07-11T06:35:33+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-id/ 2026-07-11T06:35:33+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-th/ 2026-07-11T06:35:33+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cono-pharmaceutical-co-ltd-%e8%97%a5%e5%93%81opdivo%ef%bc%88%e6%89%b9%e8%99%9f%e5%a6%82%e9%99%84%e4%bb%b6%ef%bc%89%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7-ms/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-z/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-e/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-f/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-d/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-j/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-p/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-a/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-r/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-i/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-t/ 2026-07-11T06:35:32+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-zh/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-en/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-fr/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-de/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-ja/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-pt/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-es/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-ar/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-ru/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-id/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-th/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-v/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9ccatalent-indiana-lcc%e8%97%a5%e5%93%81imfinzi%e5%9b%9e%e6%94%b6%e8%ad%a6%e8%a8%8a%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6%e6%9c%aa%e8%bc%b8%e5%85%a5%e8%a9%b2%e6%89%b9%e8%99%9f%e8%97%a5-m/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6/ 2026-07-11T06:35:31+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-fr/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-de/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-ja/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-pt/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-es/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-ar/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-ru/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-id/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-th/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-vi/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9cnovo-nordisk%e4%b8%bb%e5%8b%95%e5%9b%9e%e6%94%b6%e8%97%a5%e5%93%81ozempic-solution%ef%bc%88%e6%89%b9%e8%99%9frzffe55%e3%80%81-rzffe56%ef%bc%89%ef%bc%8c%e5%9c%8b%e5%85%a7%e4%b8%a6-ms/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-zh/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-en/ 2026-07-11T06:35:30+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-pt/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-es/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-ar/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-ru/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-id/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-th/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-vi/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-ms/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/eha-adding-pirtobrutinib-to-venetoclax-rituximab-ups-pfs-in-chronic-lymphocytic-leukemia/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-vi/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/eha-adding-pirtobrutinib-to-venetoclax-rituximab-ups-pfs-in-chronic-lymphocytic-leukemia-zh-tw/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/%e6%9c%89%e9%97%9c%e3%82%b0%e3%83%a9%e3%82%af%e3%82%bd%e3%83%bb%e3%82%b9%e3%83%9f%e3%82%b9%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%ef%bc%88gsk-plc-%ef%bc%89%e4%b8%bb-ms/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/eha-adding-pirtobrutinib-to-venetoclax-rituximab-ups-pfs-in-chronic-lymphocytic-leukemia-fr/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/eha-adding-pirtobrutinib-to-venetoclax-rituximab-ups-pfs-in-chronic-lymphocytic-leukemia-de/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-zh-tw/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/eha-adding-pirtobrutinib-to-venetoclax-rituximab-ups-pfs-in-chronic-lymphocytic-leukemia-ja/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-fr/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-de/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/bofanglutide-linked-to-meaningful-reductions-in-hba1c-in-adults-with-t2dm-ja/ 2026-07-11T06:35:29+00:00 https://keshavmed.com/news/eha-adding-pirtobrutinib-to-venetoclax-rituximab-ups-pfs-in-chronic-lymphocytic-leukemia-ru/ 2026-07-11T06:35:28+00:00 https://keshavmed.com/news/hikma-acquires-novugens-fda-approved-anda-for-trametinib-hkmp-gurufocus-vi/ 2026-07-11T06:35:28+00:00 https://keshavmed.com/news/eha-adding-pirtobrutinib-to-venetoclax-rituximab-ups-pfs-in-chronic-lymphocytic-leukemia-id/ 2026-07-11T06:35:28+00:00 https://keshavmed.com/news/eha-adding-pirtobrutinib-to-venetoclax-rituximab-ups-pfs-in-chronic-lymphocytic-leukemia-th/ 2026-07-11T06:35:28+00:00 https://keshavmed.com/news/eha-adding-pirtobrutinib-to-venetoclax-rituximab-ups-pfs-in-chronic-lymphocytic-leukemia-vi/ 2026-07-11T06:35:28+00:00